Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders

Details for Australian Patent Application No. 2005235428 (hide)

Owner Newron Pharmaceuticals S.p.A.

Inventors Barbanti, Elena; Izzo, Emanuela; Fariello, Ruggero; Salvati, Patricia; Benatti, Luca; Besana, Claudia; Thaler, Florian

Agent Lord and Company

Pub. Number AU-B-2005235428

PCT Pub. Number WO2005/102300

Priority 04009532.5 22.04.04 EP

Filing date 19 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 18 March 2010

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/198 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/102300 Priority application(s): WO2005/102300

18 March 2010 Application Accepted

  Published as AU-B-2005235428

15 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235430-Cholinesterase inhibitors in liposomes and their production and use

2005235423-Use of flibanserin in the treatment of premenstrual and other female sexual disorders